Phase I trial of oral temozolomide and intravenous O-6-benzylguanine (O-6-BG), a methylguanine methyltransferase inhibitor, in pediatric patients with recurrent brain tumors
Publication
, Conference
Broniscer, A; Gururangan, S; Goldman, S; MacDonald, T; Wallace, D; Stewart, CF; Jakacki, R; Kieran, MW; Chintagumpala, M; Banerjee, A ...
Published in: NEURO-ONCOLOGY
April 1, 2007
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
April 1, 2007
Volume
9
Issue
2
Start / End Page
189 / 189
Location
Nara, JAPAN
Publisher
DUKE UNIV PRESS
Conference Name
12th International Symposium on Pediatric Neuro-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Broniscer, A., Gururangan, S., Goldman, S., MacDonald, T., Wallace, D., Stewart, C. F., … Gajjar, A. (2007). Phase I trial of oral temozolomide and intravenous O-6-benzylguanine (O-6-BG), a methylguanine methyltransferase inhibitor, in pediatric patients with recurrent brain tumors. In NEURO-ONCOLOGY (Vol. 9, pp. 189–189). Nara, JAPAN: DUKE UNIV PRESS.
Broniscer, A., S. Gururangan, S. Goldman, T. MacDonald, D. Wallace, C. F. Stewart, R. Jakacki, et al. “Phase I trial of oral temozolomide and intravenous O-6-benzylguanine (O-6-BG), a methylguanine methyltransferase inhibitor, in pediatric patients with recurrent brain tumors.” In NEURO-ONCOLOGY, 9:189–189. DUKE UNIV PRESS, 2007.
Broniscer A, Gururangan S, Goldman S, MacDonald T, Wallace D, Stewart CF, et al. Phase I trial of oral temozolomide and intravenous O-6-benzylguanine (O-6-BG), a methylguanine methyltransferase inhibitor, in pediatric patients with recurrent brain tumors. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2007. p. 189–189.
Broniscer, A., et al. “Phase I trial of oral temozolomide and intravenous O-6-benzylguanine (O-6-BG), a methylguanine methyltransferase inhibitor, in pediatric patients with recurrent brain tumors.” NEURO-ONCOLOGY, vol. 9, no. 2, DUKE UNIV PRESS, 2007, pp. 189–189.
Broniscer A, Gururangan S, Goldman S, MacDonald T, Wallace D, Stewart CF, Jakacki R, Kieran MW, Chintagumpala M, Banerjee A, Geyer JR, Phillips P, Friedman HS, Gajjar A. Phase I trial of oral temozolomide and intravenous O-6-benzylguanine (O-6-BG), a methylguanine methyltransferase inhibitor, in pediatric patients with recurrent brain tumors. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2007. p. 189–189.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
April 1, 2007
Volume
9
Issue
2
Start / End Page
189 / 189
Location
Nara, JAPAN
Publisher
DUKE UNIV PRESS
Conference Name
12th International Symposium on Pediatric Neuro-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences